Since 2011, Ashoka – one of the world’s largest networks of social entrepreneurs and Boehringer Ingelheim – a family-owned, world-leading and research-driven Pharmaceutical company, have collaborated around a global initiative – Making More Health (MMH). Making More Health brings together the best experience in social innovation and global healthcare to improve health-care access for people and animals in underserved communities around the world.
The MMH Co-creation Accelerator, currently in its third year, is a structured social enterprise support program consisting of 12 months of design and implementation to test/pilot a new strategy or element of a business model, culminating in a pitch for further scale-up. The winners of this pitch will continue into a second 12-month phase of scale-up support of the test/pilot. (See graphic below for further details.) In both phases of the program, participants have access to financial and technical support from Ashoka, Boehringer Ingelheim and social investment experts.
A key highlight of the program is its co-creation approach that links Boehringer Ingelheim employees and participating social enterprises (based on relevant skills and expertise), so they may continue to collaborate around shared solutions for healthcare access. Upon exiting the accelerator program, participants join a growing alumni community of like-minded social entrepreneurs with continued access to technical support, best practice sharing and networking.
The program targets social entrepreneurs that meet the below selection criteria and whose organizations contribute either directly or indirectly to human & animal health access in Africa. While healthcare access lies at the core of the Making More Health program, there is also an interest in how health intersects with environmental sustainability including protection of clean water, reducing carbon emissions and smarter usage of natural resources in packaging and design.
i) Direct contribution: Innovations that contribute directly to healthcare access (for humans and animals) by providing frontline delivery of health products and services to both people as well as to farmers and their livestock. (For people, the accelerator has a particular focus on non-communicable diseases including diabetes, hypertension myocardial infarction, stroke respiratory disease and cancers.) Topics of interest include last-mile delivery, e-health solutions, disease management support services and diagnostic solutions, and one-health models.
ii) Indirect contribution: Innovations that contribute indirectly to healthcare access for humans and animals by enabling solutions that make access to healthcare more affordable, efficient, effective, accessible and sustainable. Topics of interest include health insurance innovations, data analytics, public awareness and education, emergency transport solutions, technology platforms as well as solutions combining health and environmental sustainability.
If you have an innovation that contributes to the increase in healthcare access in Africa in any of the ways described above, we are interested in receiving your application. Please review the criteria below to ensure that you qualify before applying;
|Submission of applications||1st Dec, 2020 – 7th February, 2021|
|Round one – One-on-one interviews||11th Jan – 14th February, 2021|
|Round two – Panel Interviews||26th Feb, 2021|
|Announcement of successful applicants||March, 2021|